Truist Securities Initiates Coverage On Inventiva with Buy Rating, Announces Price Target of $13
3/19/2026
Impact: 70
Healthcare
Truist Securities has initiated coverage on Inventiva (NASDAQ: IVA) with a Buy rating. The firm has set a price target of $13 for the company's stock.
AI summary, not financial advice
Share: